comparemela.com

Latest Breaking News On - Abuse deterrent pharma llc ad - Page 1 : comparemela.com

Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K -March 26, 2024 at 01:10 pm EDT

Acura Pharmaceuticals : AMENDED, CONSOLIDATED AND RESTATED SECURED PROMISSORY NOTE - Form 8-K -December 21, 2023 at 12:03 pm EST

AMENDED, CONSOLIDATED AND RESTATED SECURED PROMISSORY NOTE This AMENDMENT #1 TO AMENDED, CONSOLIDATED AND RESTATED SECURED PROMISSSORY NOTE dated November 10,.

Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT This AMENDMENT #6 (this "Amendment") TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (the "Agreement") dated June 28, 2019 between Acura Pharm.

Form DEF 14A ACURA PHARMACEUTICALS, For: May 25

Form DEF 14A ACURA PHARMACEUTICALS, For: May 25
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.